Clinical Trials
1
Active:0
Completed:1
Trial Phases
1 Phases
Phase 4:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 4
1 (100.0%)Medical Cannabis for Treating Pain Related to Fibromyalgia
Phase 4
Completed
- Conditions
- Fibromyalgia
- Interventions
- Drug: Bedrocan®-type cannabis (22% THC, <1% CBD)
- First Posted Date
- 2023-07-11
- Last Posted Date
- 2023-07-11
- Lead Sponsor
- Universita degli Studi della Basilicata
- Target Recruit Count
- 30
- Registration Number
- NCT05939466
- Locations
- 🇮🇹
Pain Therapy Unit, San Carlo Hospital, Potenza, Italy
News
No news found